To evaluate the oncogenic role of ASPM in GBM, we chose the human GBM cell lines U87, U251, and U118 to perform loss-of-function assays, as these lines express relatively higher levels of ASPM (Figure 6D, 6E). The gene discussed is ASPM; the disease is glioblastoma.